Health Care Plans And Pharmacy Benefit Managers Targeted In Class Action

Many medical benefit plan fiduciaries contract with pharmacy benefit managers (“PBMs”) to administer the prescription drug portion of their health plans, placing the PBM in charge of day-to-day management of the programs. Under the traditional PBM model, plan fiduciaries generally negotiate prescription drug prices with a PBM, which in turn negotiates pricing with drug manufacturers, profiting from the difference. This “spread pricing” has drawn the attention of policymakers in recent years. A proposed class […]

By | March 5th, 2024 ||

Future Of Health: The Emerging Landscape Of Augmented Intelligence In Health Care

In this comprehensive report, the AMA and Manatt Health explore the transformational potential of augmented intelligence (AI) in the practice of medicine and outline practical considerations for physicians who are using or considering using AI-based tools for clinical or administrative purposes.

AI in health care is not new. The use of AI in medicine dates to the mid-20th century and has been increasingly used in recent years in radiology, cardiology and neurology. Recent technological developments—such […]

By | March 3rd, 2024 ||

Telehealth Update: Controlled Substances & E/M Claims

Prior to the COVID-19 public health emergency (“PHE”), the federal Ryan Haight Act allowed a provider to prescribe controlled substance medications to a patient only after conducting an in-person evaluation of that patient (with limited exceptions). At the beginning of the PHE, the Drug Enforcement Agency (“DEA”) granted temporary exceptions to the in-person requirement and allowed the prescribing of controlled medications via telehealth encounters in order to prevent lapses in care.

As reported here earlier, […]

By | March 2nd, 2024 ||